San Diego, California — According to state and local economic development sources Mapp Biopharmaceutical plans to invest $8,011,410.00 to build out 31,175 square feet of new space in San Diego. The company plans to occupy the new space at 4921 Directors Place in San Diego, on or about May 1, 2021. According to the company website We develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense. Mapp Biopharmaceutical was founded in 2003 by Drs. Kevin Whaley and Larry Zeitlin to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.

To learn more about Mapp Biopharmaceutical, visit http://mappbio.com/

Company Contact:
Kevin Whaley, Co-Founder
kevin.whaley@mappbio.com
858-663-0432

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved